Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2025-12-25 @ 5:27 PM
Study NCT ID:
NCT04677504
Status:
COMPLETED
Last Update Posted:
2024-07-03
First Post:
2020-12-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-23
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-08-25
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-16
First Submit QC Date:
None
Study First Post Date:
2020-12-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-05-11
Results First Submit QC Date:
None
Results First Post Date:
2023-06-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-11
Last Update Post Date:
2024-07-03
Last Update Post Date Type:
ACTUAL